PMID-sentid	Pub_year	Sent_text		comp_official_name	comp_offsetprotein_name	organism	prot_offset
32200503-0	2020	CUDC-907 enhances TRAIL-induced apoptosis through upregulation of DR5 in breast cancer cells.	CUDC-907	0-8	TNF receptor superfamily member 10b	Homo sapiens	66-69	
32200503-7	2020	Knockdown of DR5 abrogated apoptosis induced by the combination of CUDC-907 and TRAIL in breast cancer cells.	CUDC-907	67-75	TNF receptor superfamily member 10b	Homo sapiens	13-16	
32200503-9	2020	JNK inhibitor pretreatment attenuated CUDC-907-induced upregulation of DR5.	CUDC-907	38-46	TNF receptor superfamily member 10b	Homo sapiens	71-74	
32200503-10	2020	In summary, CUDC-907 shows potent cytotoxicity against breast cancer cells and facilitates TRAIL-mediated apoptosis through DR5 upregulation.	CUDC-907	12-20	TNF receptor superfamily member 10b	Homo sapiens	124-127	
32200503-6	2020	CUDC-907 enhanced expressions of death receptor 5 (DR5), reduced the levels of anti-apoptotic molecules XIAP, Bcl-2 and Bcl-xL.	CUDC-907	0-8	TNF receptor superfamily member 10b	Homo sapiens	33-49	
32200503-6	2020	CUDC-907 enhanced expressions of death receptor 5 (DR5), reduced the levels of anti-apoptotic molecules XIAP, Bcl-2 and Bcl-xL.	CUDC-907	0-8	TNF receptor superfamily member 10b	Homo sapiens	51-54